Evidence map›Paper›PMID 8052597›Full record

ReviewProceedings of the National Academy of Sciences of the United States of America1994

Dissection of an antibody-catalyzed reaction.

J D Stewart, J F Krebs, G Siuzdak, A J Berdis, D B Smithrud, S J Benkovic

Open access · greenAbstract readReview
In one paragraph

Review in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 47 citations in OpenAlex.

  1. Synthetic, Switchable Enzymes.Journal of molecular microbiology and biotechnology · 2017
    Review
  2. Article
  3. De novo proteins from designed combinatorial libraries.Protein science : a publication of the Protein Society · 2004
    Review
  4. Enzyme mimicry by the antiidiotypic antibody approach.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  5. Phage display of a catalytic antibody to optimize affinity for transition-state analog binding.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  6. Article
  7. Mechanistically different catalytic antibodies obtained from immunization with a single transition-state analog.Proceedings of the National Academy of Sciences of the United States of America · 1995
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

J D StewartDepartment of Chemistry, Pennsylvania State University, University Park 16802.
J F Krebs
G Siuzdak
A J Berdis
D B Smithrud
S J Benkovic
Pennsylvania State University · USScripps Research Institute · US

Funding

NIGMS NIH HHS GM 15536-02
6 · The paper itself

Abstract

Antibody 43C9 accelerates the hydrolysis of a p-nitroanilide by a factor of 2.5 x 10(5) over the background rate in addition to catalyzing the hydrolysis of a series of aromatic esters. Since this represents one of the largest rate accelerations achieved with an antibody, we have undertaken a series of studies aimed at uncovering the catalytic mechanism of 43C9. The immunogen, a phosphonamidate, was designed to mimic the geometric and electronic characteristics of the tetrahedral intermediate that forms upon nucleophilic attack by hydroxide on the amide substrate. Further studies, however, revealed that the catalytic mechanism is more complex and involves the fortuitous formation of a covalent acyl-antibody intermediate as a consequence of complementary side chain residues at the antibody-binding site. Several lines of evidence indicate that the catalytic mechanism involves two key residues: His-L91, which acts as a nucleophile to form the acyl-antibody intermediate, and Arg-L96, which stabilizes the anionic tetrahedral moieties. Support for this mechanism derives from the results of site-directed mutagenesis experiments and solvent deuterium isotope effects as well as direct detection of the acyl-antibody by electrospray mass spectrometry. Despite its partial recapitulation of the course of action of enzymic counterparts, the reactivity of 43C9, like other antibodies, is apparently limited by its affinity for the inducing immunogen. To go beyond this level, one must introduce additional catalytic functionality, particularly general acid-base catalysis, through either improvements in transition-state analog design or site-specific mutagenesis.

Indexed as

Aniline CompoundsAntibodies, CatalyticBinding SitesCatalysisAniline CompoundsAntibodies, Catalytic

Identifiers

PMID8052597
PMCPMC44409
OpenAlexW1990200501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.